{
  "issues": [
    "Renal function labs (eGFR, serum creatinine, BUN, potassium) are missing; the renal tool flagged critical gaps.",
    "The renal tool summary lists additional missing data (BMI, lab timestamps) that were not supplied in the patient record.",
    "Agent 2 selected two contrast‑enhanced CT protocols (liver LI‑RADS and trauma torso) without a confirmed clinical indication for either study.",
    "Both suggested protocols rely on contrast administration despite absent renal function data, which is unsafe for patients at risk of contrast‑induced nephropathy.",
    "References cited in the protocol definitions are placeholder Wikipedia links and an internal PDF citation; they do not meet evidence‑based standards.",
    "Patient‑level data (primary diagnosis, admission type) are placeholders (“Extracted from FHIR”), preventing any definitive assessment of urgency or appropriateness of contrast use."
  ],
  "recommendations": [
    "Obtain STAT renal function labs (eGFR, serum creatinine, BUN, potassium) with exact timestamps before planning any contrast‑enhanced study.",
    "Clarify the precise clinical indication for imaging (e.g., suspected liver lesion, trauma evaluation, active hemorrhage) and document urgency (emergent vs. non‑emergent).",
    "If the indication is non‑emergent, defer contrast‑enhanced CT until renal labs are available; consider non‑contrast CT, MRI without gadolinium, or ultrasound as alternatives.",
    "If the indication is emergent (e.g., active intra‑abdominal hemorrhage), proceed with the lowest feasible iodine dose, employ split‑bolus or reduced‑volume techniques, and ensure aggressive IV hydration per KDIGO guidelines (e.g., isotonic saline 1 mL/kg/h beginning before contrast and continuing for 12 h).",
    "Select a protocol only after renal function is known: for eGFR ≥60 mL/min/1.73 m², standard contrast dosing is acceptable; for eGFR 30‑59, use reduced dose and consider iso‑osmolar contrast; for eGFR <30, avoid iodinated contrast unless life‑threatening and no alternative exists.",
    "Replace all placeholder references with peer‑reviewed sources (e.g., ACR Appropriateness Criteria, KDIGO 2024 guideline, ACR–SPR practice parameters).",
    "Document renal safety notes explicitly in the order set, including hydration protocol, post‑contrast monitoring, and criteria for dialysis if needed.",
    "Re‑evaluate the chosen CT protocols once the indication and renal status are confirmed; for liver lesion work‑up, a non‑contrast MRI with liver‑specific contrast (gadoxetate) may be safer in renal impairment."
  ],
  "confidence": 0.16999999999999998,
  "agent2_confidence": 0.78,
  "timestamp": "2025-09-08T16:56:16.736304Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-09-08T16:56:11.136277Z",
          "priority": "critical",
          "value": null,
          "status": "missing",
          "reason": "eGFR not available"
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-09-08T16:56:11.136297Z",
          "priority": "critical",
          "value": null,
          "status": "missing",
          "reason": "Creatinine not available"
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-09-08T16:56:11.136307Z",
          "priority": "important",
          "value": null,
          "status": "missing",
          "reason": "Missing BUN or creatinine for ratio."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-09-08T16:56:11.136316Z",
          "priority": "important",
          "value": null,
          "status": "missing",
          "reason": "Potassium not available"
        }
      ],
      "summary": {
        "overall": "fail",
        "reasons": [
          "eGFR not available",
          "Creatinine not available",
          "Missing BUN or creatinine for ratio.",
          "Potassium not available",
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.52
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-09-08T16:56:11.136374Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Renal function labs (eGFR, serum creatinine, BUN, potassium) are missing; the renal tool flagged critical gaps.\",\n    \"The renal tool summary lists additional missing data (BMI, lab timestamps) that were not supplied in the patient record.\",\n    \"Agent 2 selected two contrast‑enhanced CT protocols (liver LI‑RADS and trauma torso) without a confirmed clinical indication for either study.\",\n    \"Both suggested protocols rely on contrast administration despite absent renal function data, which is unsafe for patients at risk of contrast‑induced nephropathy.\",\n    \"References cited in the protocol definitions are placeholder Wikipedia links and an internal PDF citation; they do not meet evidence‑based standards.\",\n    \"Patient‑level data (primary diagnosis, admission type) are placeholders (“Extracted from FHIR”), preventing any definitive assessment of urgency or appropriateness of contrast use.\"\n  ],\n  \"recommendations\": [\n    \"Obtain STAT renal function labs (eGFR, serum creatinine, BUN, potassium) with exact timestamps before planning any contrast‑enhanced study.\",\n    \"Clarify the precise clinical indication for imaging (e.g., suspected liver lesion, trauma evaluation, active hemorrhage) and document urgency (emergent vs. non‑emergent).\",\n    \"If the indication is non‑emergent, defer contrast‑enhanced CT until renal labs are available; consider non‑contrast CT, MRI without gadolinium, or ultrasound as alternatives.\",\n    \"If the indication is emergent (e.g., active intra‑abdominal hemorrhage), proceed with the lowest feasible iodine dose, employ split‑bolus or reduced‑volume techniques, and ensure aggressive IV hydration per KDIGO guidelines (e.g., isotonic saline 1 mL/kg/h beginning before contrast and continuing for 12 h).\",\n    \"Select a protocol only after renal function is known: for eGFR ≥60 mL/min/1.73 m², standard contrast dosing is acceptable; for eGFR 30‑59, use reduced dose and consider iso‑osmolar contrast; for eGFR <30, avoid iodinated contrast unless life‑threatening and no alternative exists.\",\n    \"Replace all placeholder references with peer‑reviewed sources (e.g., ACR Appropriateness Criteria, KDIGO 2024 guideline, ACR–SPR practice parameters).\",\n    \"Document renal safety notes explicitly in the order set, including hydration protocol, post‑contrast monitoring, and criteria for dialysis if needed.\",\n    \"Re‑evaluate the chosen CT protocols once the indication and renal status are confirmed; for liver lesion work‑up, a non‑contrast MRI with liver‑specific contrast (gadoxetate) may be safer in renal impairment.\"\n  ],\n  \"confidence\": 0.42\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Renal function labs (eGFR, serum creatinine, BUN, potassium) are missing; the renal tool flagged critical gaps.",
        "type": "issue",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "The renal tool summary lists additional missing data (BMI, lab timestamps) that were not supplied in the patient record.",
        "type": "issue",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Agent 2 selected two contrast‑enhanced CT protocols (liver LI‑RADS and trauma torso) without a confirmed clinical indication for either study.",
        "type": "issue",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Both suggested protocols rely on contrast administration despite absent renal function data, which is unsafe for patients at risk of contrast‑induced nephropathy.",
        "type": "issue",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "References cited in the protocol definitions are placeholder Wikipedia links and an internal PDF citation; they do not meet evidence‑based standards.",
        "type": "issue",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Patient‑level data (primary diagnosis, admission type) are placeholders (“Extracted from FHIR”), preventing any definitive assessment of urgency or appropriateness of contrast use.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'extracted from fhir'"
      },
      {
        "text": "Obtain STAT renal function labs (eGFR, serum creatinine, BUN, potassium) with exact timestamps before planning any contrast‑enhanced study.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Clarify the precise clinical indication for imaging (e.g., suspected liver lesion, trauma evaluation, active hemorrhage) and document urgency (emergent vs. non‑emergent).",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "If the indication is non‑emergent, defer contrast‑enhanced CT until renal labs are available; consider non‑contrast CT, MRI without gadolinium, or ultrasound as alternatives.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "If the indication is emergent (e.g., active intra‑abdominal hemorrhage), proceed with the lowest feasible iodine dose, employ split‑bolus or reduced‑volume techniques, and ensure aggressive IV hydration per KDIGO guidelines (e.g., isotonic saline 1 mL/kg/h beginning before contrast and continuing for 12 h).",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Select a protocol only after renal function is known: for eGFR ≥60 mL/min/1.73 m², standard contrast dosing is acceptable; for eGFR 30‑59, use reduced dose and consider iso‑osmolar contrast; for eGFR <30, avoid iodinated contrast unless life‑threatening and no alternative exists.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "egfr 60.0 not present in KB"
      },
      {
        "text": "Replace all placeholder references with peer‑reviewed sources (e.g., ACR Appropriateness Criteria, KDIGO 2024 guideline, ACR–SPR practice parameters).",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Document renal safety notes explicitly in the order set, including hydration protocol, post‑contrast monitoring, and criteria for dialysis if needed.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Re‑evaluate the chosen CT protocols once the indication and renal status are confirmed; for liver lesion work‑up, a non‑contrast MRI with liver‑specific contrast (gadoxetate) may be safer in renal impairment.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      }
    ],
    "counts": {
      "supported": 1,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 13,
      "contradicted": 0
    },
    "hallucination_score": 0.464,
    "recommendation": {
      "force_revision": true,
      "confidence_reduction": 0.25
    },
    "knowledge_base_summary": {
      "numbers": {},
      "raw_strings_sample": [
        "creatinine not available",
        "egfr_ckd_epi",
        "potassium_mmol_l",
        "creatinine_mg_dl",
        "fhir_based",
        "bun_creatinine_ratio",
        "missing bun or creatinine for ratio.",
        "potassium not available",
        "extracted from fhir",
        "egfr not available"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Renal function labs (eGFR, serum creatinine, BUN, potassium) are missing; the renal tool flagged critical gaps.",
      "The renal tool summary lists additional missing data (BMI, lab timestamps) that were not supplied in the patient record.",
      "Agent 2 selected two contrast‑enhanced CT protocols (liver LI‑RADS and trauma torso) without a confirmed clinical indication for either study.",
      "Both suggested protocols rely on contrast administration despite absent renal function data, which is unsafe for patients at risk of contrast‑induced nephropathy.",
      "References cited in the protocol definitions are placeholder Wikipedia links and an internal PDF citation; they do not meet evidence‑based standards.",
      "Patient‑level data (primary diagnosis, admission type) are placeholders (“Extracted from FHIR”), preventing any definitive assessment of urgency or appropriateness of contrast use."
    ],
    "recommendations": [
      "Obtain STAT renal function labs (eGFR, serum creatinine, BUN, potassium) with exact timestamps before planning any contrast‑enhanced study.",
      "Clarify the precise clinical indication for imaging (e.g., suspected liver lesion, trauma evaluation, active hemorrhage) and document urgency (emergent vs. non‑emergent).",
      "If the indication is non‑emergent, defer contrast‑enhanced CT until renal labs are available; consider non‑contrast CT, MRI without gadolinium, or ultrasound as alternatives.",
      "If the indication is emergent (e.g., active intra‑abdominal hemorrhage), proceed with the lowest feasible iodine dose, employ split‑bolus or reduced‑volume techniques, and ensure aggressive IV hydration per KDIGO guidelines (e.g., isotonic saline 1 mL/kg/h beginning before contrast and continuing for 12 h).",
      "Select a protocol only after renal function is known: for eGFR ≥60 mL/min/1.73 m², standard contrast dosing is acceptable; for eGFR 30‑59, use reduced dose and consider iso‑osmolar contrast; for eGFR <30, avoid iodinated contrast unless life‑threatening and no alternative exists.",
      "Replace all placeholder references with peer‑reviewed sources (e.g., ACR Appropriateness Criteria, KDIGO 2024 guideline, ACR–SPR practice parameters).",
      "Document renal safety notes explicitly in the order set, including hydration protocol, post‑contrast monitoring, and criteria for dialysis if needed.",
      "Re‑evaluate the chosen CT protocols once the indication and renal status are confirmed; for liver lesion work‑up, a non‑contrast MRI with liver‑specific contrast (gadoxetate) may be safer in renal impairment."
    ],
    "confidence": 0.16999999999999998
  }
}